Solara Active Pharma Sciences Limited (SOLARA.BO)
INR 509.6
(3.02%)
INR 509.6
(3.02%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 4.57 Billion INR | -27.57% |
| 2022 | 6.32 Billion INR | -2.24% |
| 2021 | 6.46 Billion INR | 23.57% |
| 2020 | 5.23 Billion INR | 13.33% |
| 2019 | 4.61 Billion INR | 8.83% |
| 2018 | 4.24 Billion INR | 850.65% |
| 2017 | 446.43 Million INR | -88.25% |
| 2016 | 3.79 Billion INR | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 649.8 Million INR | -66.93% |
| 2024 Q2 | 1.39 Billion INR | -6.06% |
| 2023 Q4 | 1.96 Billion INR | 121.77% |
| 2023 Q1 | 1.67 Billion INR | 0.75% |
| 2023 Q2 | 1.76 Billion INR | 5.49% |
| 2023 FY | 4.57 Billion INR | -27.57% |
| 2023 Q3 | 886 Million INR | -49.74% |
| 2022 Q2 | 1.5 Billion INR | 0.0% |
| 2022 Q4 | 1.65 Billion INR | -0.28% |
| 2022 FY | 6.32 Billion INR | -2.24% |
| 2022 Q1 | 1.5 Billion INR | 213.11% |
| 2022 Q3 | 1.66 Billion INR | 10.86% |
| 2021 Q4 | 479.2 Million INR | -72.05% |
| 2021 FY | 6.46 Billion INR | 23.57% |
| 2021 Q3 | 1.71 Billion INR | 0.26% |
| 2021 Q2 | 1.71 Billion INR | 4.68% |
| 2021 Q1 | 1.63 Billion INR | 132.95% |
| 2020 FY | 5.23 Billion INR | 13.33% |
| 2020 Q2 | 1.53 Billion INR | 8.65% |
| 2020 Q1 | 1.41 Billion INR | 246.68% |
| 2020 Q3 | 1.61 Billion INR | 5.0% |
| 2020 Q4 | 701.3 Million INR | -56.45% |
| 2019 Q4 | 407.2 Million INR | -71.26% |
| 2019 FY | 4.61 Billion INR | 8.83% |
| 2019 Q3 | 1.41 Billion INR | 3.41% |
| 2019 Q2 | 1.36 Billion INR | -0.49% |
| 2019 Q1 | 1.37 Billion INR | 500.6% |
| 2018 Q4 | 229.22 Million INR | -83.62% |
| 2018 FY | 4.24 Billion INR | 850.65% |
| 2018 Q1 | 1.23 Billion INR | -3.52% |
| 2018 Q2 | 1.37 Billion INR | 10.94% |
| 2018 Q3 | 1.39 Billion INR | 1.73% |
| 2017 Q4 | 1.28 Billion INR | 0.0% |
| 2017 Q2 | 73.38 Million INR | -93.15% |
| 2017 Q1 | 1.07 Billion INR | 0.0% |
| 2017 FY | 446.43 Million INR | -88.25% |
| 2016 FY | 3.79 Billion INR | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 15.86 Billion INR | 71.142% |
| Aurobindo Pharma Limited | 39.23 Billion INR | 88.328% |
| Glenmark Life Sciences Limited | 11.64 Billion INR | 60.658% |
| Granules India Limited | 7.18 Billion INR | 36.237% |
| Indoco Remedies Limited | 4.74 Billion INR | 3.56% |
| Achyut Healthcare Limited | 1.6 Million INR | -284530.205% |
| Ajanta Pharma Limited | 30.46 Billion INR | 84.966% |
| Alkem Laboratories Limited | 32.83 Billion INR | 86.052% |
| Alpa Laboratories Limited | 156.14 Million INR | -2832.941% |
| Brooks Laboratories Limited | 51.18 Million INR | -8848.222% |
| AstraZeneca Pharma India Limited | 2.6 Billion INR | -76.115% |
| Bajaj HealthCare Limited | 985.34 Million INR | -364.781% |
| Bliss GVS Pharma Limited | 1.41 Billion INR | -222.691% |
| Dr. Reddy's Laboratories Limited | 95.87 Billion INR | 95.223% |
| Eris Lifesciences Limited | 4.94 Billion INR | 7.349% |
| FDC Limited | 5.34 Billion INR | 14.375% |
| Glenmark Pharmaceuticals Limited | 67.56 Billion INR | 93.222% |
| Gufic Biosciences Limited | 1.07 Billion INR | -324.947% |
| Ind-Swift Laboratories Limited | 2.12 Billion INR | -115.598% |
| Ipca Laboratories Limited | 13.91 Billion INR | 67.088% |
| Jagsonpal Pharmaceuticals Limited | 773.41 Million INR | -492.144% |
| Krebs Biochemicals & Industries Limited | 46.15 Million INR | -9822.22% |
| Lasa Supergenerics Limited | 291.17 Million INR | -1472.84% |
| Laurus Labs Limited | 3.01 Billion INR | -52.109% |
| Lupin Limited | 95.67 Billion INR | 95.213% |
| Mankind Pharma Limited | 23.15 Billion INR | 80.22% |
| Medicamen Biotech Limited | 335.16 Million INR | -1266.393% |
| Medico Remedies Limited | 161.84 Million INR | -2729.7% |
| Megasoft Limited | 49.52 Million INR | -9146.689% |
| NATCO Pharma Limited | 10.05 Billion INR | 54.467% |
| Piramal Pharma Limited | 19.91 Billion INR | 77.003% |
| RPG Life Sciences Limited | 1.63 Billion INR | -180.018% |
| Sigachi Industries Limited | 579.88 Million INR | -689.757% |
| Sun Pharmaceutical Industries Limited | 154.18 Billion INR | 97.03% |
| Suven Pharmaceuticals Limited | 1.4 Billion INR | -226.471% |
| Syncom Formulations (India) Limited | 942.39 Million INR | -385.962% |
| Unichem Laboratories Limited | 6.72 Billion INR | 31.909% |
| Wanbury Limited | 1.16 Billion INR | -294.486% |
| Windlas Biotech Limited | 1 Billion INR | -355.008% |
| ZIM Laboratories Limited | 1.01 Billion INR | -352.067% |
| Zydus Lifesciences Limited | 43.17 Billion INR | 89.392% |
| Sun Pharma Advanced Research Company Limited | 3.07 Billion INR | -48.846% |
| Divi's Laboratories Limited | 14.17 Billion INR | 67.68% |
| Hester Biosciences Limited | 908.84 Million INR | -403.906% |
| Procter & Gamble Health Limited | 2.99 Billion INR | -52.891% |
| Amrutanjan Health Care Limited | 1.09 Billion INR | -316.72% |
| Bal Pharma Limited | 389.89 Million INR | -1074.613% |
| Strides Pharma Science Limited | 9.16 Billion INR | 50.016% |
| Venus Remedies Limited | 1.91 Billion INR | -138.989% |
| Aarti Pharmalabs Limited | 3.07 Billion INR | -48.962% |
| Nectar Lifesciences Limited | 625.55 Million INR | -632.108% |
| Shilpa Medicare Limited | 2.18 Billion INR | -110.021% |
| Aarti Drugs Limited | 1.16 Billion INR | -292.273% |
| IOL Chemicals and Pharmaceuticals Limited | 1.09 Billion INR | -316.791% |
| Suven Life Sciences Limited | 109.75 Million INR | -4072.847% |
| Ind-Swift Limited | 946.56 Million INR | -383.822% |
| Valiant Laboratories Limited | 36.28 Million INR | -12520.078% |
| J. B. Chemicals & Pharmaceuticals Limited | 8.41 Billion INR | 45.59% |
| Themis Medicare Limited | 782.85 Million INR | -485.0% |
| Hikal Limited | 2.48 Billion INR | -84.194% |
| Torrent Pharmaceuticals Limited | 21.42 Billion INR | 78.622% |
| Sequent Scientific Limited | 2.9 Billion INR | -57.822% |
| Novartis India Limited | 470.1 Million INR | -874.197% |
| Wockhardt Limited | 6.4 Billion INR | 28.442% |
| Jubilant Pharmova Limited | 14.45 Billion INR | 68.315% |
| Biofil Chemicals and Pharmaceuticals Limited | 16.2 Million INR | -28152.838% |
| Neuland Laboratories Limited | 2.92 Billion INR | -56.317% |
| Morepen Laboratories Limited | 1.98 Billion INR | -130.431% |
| Kilitch Drugs (India) Limited | 412.42 Million INR | -1010.427% |
| Mangalam Drugs & Organics Limited | 676.14 Million INR | -577.323% |